ID
43789
Beskrivning
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications; ODM derived from: https://clinicaltrials.gov/show/NCT02082249
Länk
https://clinicaltrials.gov/show/NCT02082249
Nyckelord
Versioner (2)
- 2016-05-01 2016-05-01 -
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Advanced Parkinson's Disease NCT02082249
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
subject is enrolled in another clinical trial
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Beskrivning
interfere with patient
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0525058
- UMLS CUI [2]
- C0525058
- UMLS CUI [3]
- C0004936
Beskrivning
contraindication to continued levodopa therapy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1301624
- UMLS CUI [2]
- C0023570
Beskrivning
Patient Non-Compliance
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0376405
Beskrivning
suicidal ideation
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0424000
Beskrivning
unsuitable candidate to continue to receive
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C3839545
- UMLS CUI [1,2]
- C2002915
Similar models
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
C0525058 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0023570 (UMLS CUI [2])
C2002915 (UMLS CUI [1,2])